Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents and Age Related Macular Degeneration Complications

NACompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

April 28, 2016

Primary Completion Date

May 5, 2020

Conditions
Subretinal Haematoma Linked to AMD
Interventions
OTHER

Surgery

OTHER

Intravitreal injections of gas

PROCEDURE

injections of an antiangiogenic

Trial Locations (17)

21079

CHU de DIJON, Dijon

25030

CHU de BESANCON, Besançon

31300

CHU de TOULOUSE - Hôpital Purpan, Toulouse

33000

CHU de Bordeaux, Bordeaux

38043

CHU de GRENOBLE, Grenoble

51092

CHU de REIMS, Reims

54500

CHU de NANCY, Vandœuvre-lès-Nancy

57085

CHR de METZ-THIONVILLE, Metz

58000

CH de NEVERS, Nevers

67091

NHC de STRASBOURG, Strasbourg

68000

CH de COLMAR, Colmar

68100

CH de MULHOUSE, Mulhouse

69004

HCL - Hôpital de la Croix-Rousse, Lyon

75010

AP-HP Hôpital Lariboisière, Paris

75019

Fondation Ophtalmologique A. de Rothschild, Paris

76100

Clinique Mathilde, Rouen

94000

CHI de CRETEIL, Créteil

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT02557451 - Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents and Age Related Macular Degeneration Complications | Biotech Hunter | Biotech Hunter